These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28429547)

  • 1. The use of bone turnover markers in chronic kidney disease-mineral and bone disorders.
    Chiang C
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():11-13. PubMed ID: 28429547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
    Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
    Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
    Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
    BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
    Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
    Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy.
    Jørgensen HS; Behets G; Viaene L; Bammens B; Claes K; Meijers B; Naesens M; Sprangers B; Kuypers D; Cavalier E; D'Haese P; Evenepoel P
    Am J Kidney Dis; 2022 May; 79(5):667-676.e1. PubMed ID: 34710517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach for evaluating bone turnover in chronic kidney disease.
    Tolouian R; Hernandez GT; Chiang WY; Gupta A
    Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
    Pazianas M; Miller PD
    Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation].
    Kusec V; Smalcelj R
    Acta Med Croatica; 2004; 58(1):51-7. PubMed ID: 15125394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Nihon Rinsho; 2006 Sep; 64(9):1703-6. PubMed ID: 16972683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
    Ursem SR; Heijboer AC; D'Haese PC; Behets GJ; Cavalier E; Vervloet MG; Evenepoel P
    Kidney Int; 2021 May; 99(5):1173-1178. PubMed ID: 33422551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
    Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
    Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adynamic bone disease: from bone to vessels in chronic kidney disease.
    Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
    Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis and adynamic bone in chronic kidney disease.
    Cannata-Andía JB; Rodriguez García M; Gómez Alonso C
    J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone alkaline phosphatase in CKD-mineral bone disorder.
    Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
    Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating markers of bone turnover.
    Vervloet MG; Brandenburg VM;
    J Nephrol; 2017 Oct; 30(5):663-670. PubMed ID: 28502032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.